1 / 16

Advanced Library Generation

Advanced Library Generation. Tobias Knaute / Johannes Zerweck Peptide Arrays JPT Peptide Technologies, Berlin. What´s the Problem?. The peptide library generation for determining antibody / antigen interactions gets complex if many proteins are involved

booth
Télécharger la présentation

Advanced Library Generation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Advanced Library Generation Tobias Knaute / Johannes Zerweck Peptide Arrays JPT Peptide Technologies, Berlin

  2. What´sthe Problem? • The peptidelibrarygenerationfordeterminingantibody / antigeninteractionsgetscomplexifmanyproteinsareinvolved • Post-translationalmodificationsincreasecomplexityevenmore • Numberofpeptidesis limited due to experimental setup (max. 7000 peptides per experiment) • Problem: Howtogeneratethemostefficientlibraryconcerningcoverageandcontent

  3. Conventional MethodFixed Overlap C N Overlap = Length - Offset Generation of overlapping peptides based on primary structure MGARASVLSGGELDR RASVLSGGELDRWEK VLSGGELDRWEKIRL GGELDRWEKIRLRPG LDRWEKIRLRPGGKK ... MGARASVLSGGELDR RASVLSGGELDRWEK VLSGGELDRWEKIRL GGELDRWEKIRLRPG LDRWEKIRLRPGGKK ... • PRO: • Easy to understand & implement • Sufficientfor simple screeningsandepitopemappings • CON: • Insufficientformanyhomologoussequences • Couldleadtobloatedpeptidelists • Coverage not adjustable

  4. AdvancedMethodDynamicalOverlap • Algorithmenabling optimal coverageofproteinsequencesbypeptidelibraries • Task 1: find optimumbetweennumberofpeptidesandcoverage • Task 2: generatepeptide-score accordingtofrequencyofmotifs (e.g. in otherhomologoussequences) • Task 3: abilitytoinjectfixedsequences (e.g. frompreviousprojects) • Task 4: abilitytoadjustcoverageand/ornumberofpeptidestospecificneeds

  5. Example Protein 1 Protein 2 Task: - 2 homologoussequences - makepeptidescan - peptidelength 15 - maximumoverlap11 - makesureeveryresidueiscoveredbyat least 3 peptides

  6. Example - Convential Scan Convential scan Fixed overlap 15/11 Peptides of protein 1 Peptides Protein 1 Protein 2

  7. Example - Convential Scan Convential scan Fixed overlap 15/11 Peptides of protein 2 Peptides Protein 1 Protein 2

  8. Example - Convential Scan Convential scan Fixed overlap 15/11 All individual peptides, mapped to protein 1  Several peptides from protein 2 fit into sequence of protein 1 Number of peptides covering specific amino acid in protein sequence  amino acid coverage Peptides 4 5 6 7 8 7 7 7 5 4 Protein 1 Protein 2 Redundancy introduced by homology.

  9. Example - DynamicalOverlap All peptides, mapped to protein 1  Redundant peptides are rejected by algorithm overlap 8 Amino acid coverage is optimized Peptides 3 3 4 4 4 4 4 4 3 Protein 1 Protein 2 Overlap adjustable by coverage constraint.

  10. Case Study: HIV1 ENV gp16024 Sequencesof Group M Subtype B Task: Minimum coverage: 3 peptides/residue Length: 15 Max. overlap: 11 highly conserved region highly variable region 3283 peptides needed for traditional method 2303 peptidesneeded for advanced method

  11. Case Study: HIV1 ENV gp160ResidueCoverageMap Conventional 3283 peptides mean density: 6.7 peptides/residue Advanced 2303 peptides meandensity: 3.7 peptides/residue

  12. Summary • Algorithmtobuild optimal librariesdeveloped • Coverage / numberofpeptidescanbeadjusted • Elimination of redundant motifs • Addressesdiversity, bestsuitedforproteome-widesequencealignments in complexlibraries • ApplicabletoPepStarTMmicroarrays, PepTrackTM Libraries, PepMixTMpeptidepools ... • Based on theinputofproteinsequences, JPT will develop an optimizedlibraryforseroprofilingor immune monitoringexperiments

  13. JPT Peptide Technologies

  14. History 1994 Jerini Spin-Off from Charité Clinics Berlin 2002 Jerini Peptide Technologies - Business Unit 2004 JPT Peptide Technologies GmbH 2005 JPT Inc. in Boston, MA, USA 2006 New JPT Facilities in Berlin 2009 AcquisitionbyBioNTech AG 2011 50 Employees, 13 PhD‘s Offices & Reps Berlin, Boston, Denver, Brussels 1500 sqm wet lab and 1200 sqm office space Capabilities for organic & biological laboratory work Approved S2 lab for infectious patient samples Cleanroom microarray capabilities Business develoment & marketing History, Quality Assurance & Business Model • Quality Assurance • 2002 Quality Management System • 2004 DIN ISO 9001:2000 Certification • Since 2008 GCLP Compliance Audits (NIH, IAVI, BCM, Cellmedica, Genticel...) • 2010 DIN ISO 9001:2008 Certification • Business Model http://jpt.com http://shop.jpt.com http://rnd.jpt.com

  15. Major Application Fields of Peptides Immunology Vaccine development B- and T-cell epitope discovery Diagnostic tools for infectious, autoimmune diseases, allergies & cancer Immune monitoring & immune therapies Proteomics & Enzyme Profiling • Enzyme profiling and protein/protein interaction studies • Quantification of protein expression levels • Biomarker discovery Drug Discovery • Biomedical screening • Peptide therapeutics • SAR, structure activity relationship studies

  16. Feelfreetodiscussyourspecificneedswithourexperts ! JPT Peptide Technologies GmbHVolmerstrasse 512489 Berlin, GermanyT +49-30-6392-5500X +49-30-6392-5501info@jpt.com www.jpt.com • > http://jpt.com • for Custom Products & Services- > http://rnd.jpt.com • for Peptide Related Collaboration Projects • - > http://shop.jpt.com • for Catalog Products

More Related